Human neural stem cell secretome relieves endoplasmic reticulum stress-induced apoptosis and improves neuronal functions after traumatic brain injury in a rat model.
Yating LingMurugan RamalingamXiaorui LvDongdong NiuYu ZengYun QiuYu SiTao GuoYinying NiJingwen ZhangZiyu WangHae-Won KimJiabo HuPublished in: Journal of molecular histology (2024)
Neural stem cell secretome (NSC-S) plays an important role in neuroprotection and recovery. Studies have shown that endoplasmic reticulum stress (ER stress) is involved in the progression of traumatic brain injury (TBI) and is a crucial cause of secondary damage and neuronal death after brain injury. Whether NSC-S is engaged in ER stress and ER stress-mediated neuronal apoptosis post-TBI has not been investigated. In the study, the Feeney SD male rat model was established. The results showed that NSC-S treatment significantly improved the behavior of rats with TBI. In addition, NSC-S relieved ER stress in TBI rats and was observed by transmission electron microscopy and western blot. The specific mechanism was further elucidated that restoration was achieved by alleviating the PERK-eIF2α pathway and thus protecting neurons from apoptosis. Notably, the discovery of calumenin (CALU) in NSC-S by liquid chromatography-tandem mass spectrometry (LC-MS/MS/MS) may be related to the protective effect of NSC-S on ER stress in neurons. Also, the mechanism by which it functions may be related to ubiquitination. In summary, NSC-S improved prognosis and ER stress in TBI rats and might be a promising treatment for relieving TBI.
Keyphrases
- endoplasmic reticulum stress
- traumatic brain injury
- induced apoptosis
- brain injury
- stem cells
- liquid chromatography tandem mass spectrometry
- cerebral ischemia
- severe traumatic brain injury
- ms ms
- subarachnoid hemorrhage
- mild traumatic brain injury
- oxidative stress
- spinal cord
- endothelial cells
- electron microscopy
- signaling pathway
- small molecule
- high throughput
- blood brain barrier
- cell therapy
- drug induced
- pluripotent stem cells